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Recommendations to Enhance US Surveillance for Influenza A(H5N1)
As you are aware, two human cases of influenza A (H5N1) have been confirmed in a single family of 
Hong Kong residents who recently traveled to Fujian Province on mainland China. The first patient, a 
9-year-old boy, was hospitalized in Hong Kong but is recovering. The second patient, the father of the 
9-year-old boy, died in a Hong Kong hospital on February 17, 2003. Additional family members had 
respiratory symptoms, and the boy's 8-year-old sister died while the family was in China. The cause 
of her death and the other respiratory illnesses in her family is not known. There is currently 
insufficient information to determine whether this family was infected from a common source or 
whether illness spread within the family from person to person.
In response to the reports of these 2 cases, CDC is issuing recommendations for enhanced 
influenza surveillance for state health departments. The purpose of these recommendations is 
to enhance the capacity to rapidly identify an importation of influenza A (H5N1) into the United 
States from Asia while maintaining effective public health response capacity. The 
enhancements will occur in a stepwise fashion based on the evolution of influenza A (H5N1) 
activity.
Enclosed are recommendations for enhanced influenza surveillance activities that should be 
implemented immediately as well as activities that should be implemented if influenza A 
(H5N1) cases are identified outside Hong Kong or the Chinese mainland or evidence of 
efficient, sustained, person-to-person transmission is established. We will continue to provide 
you with updates on influenza A (H5N1) activity and will distribute recommendations on any 
additional surveillance activities that may become necessary.
Thank you for your time and help with these efforts. If you have any questions, please contact 
Lynnette Brammer (lbrammer@cdc.gov) or Alicia Postema (apostema@cdc.gov) at 404-639­
3747.
Sincerely,
Lynnette Brammer, MPH 
Influenza Branch
Centers for Disease Control and Prevention
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Objective
To enhance the capacity to rapidly identify an importation of influenza A(H5N1) into the United 
States from Asia while maintaining effective public health response capacity.
Recommendations
Surveillance enhancements will occur in a stepwise fashion based on the evolution of influenza 
A(H5N1) activity.
Step 1. Activities for immediate implementation
Laboratory surveillance
All US World Health Organization/National Respiratory and Enteric Virus 
Surveillance System collaborating laboratories should subtype all influenza A 
viruses identified in clinical specimens, if possible. As always, any unsubtypable 
influenza A virus should be reported to the CDC Influenza Branch immediately 
(Dr. Alexander Klimov, 404-639-3591).
Sentinel provider surveillance:
States at less than 75% of their sentinel provider goal of 1 regularly reporting site 
per 250,000 population (or a minimum of 10 sites in smaller, less populous 
states) should consider recruiting and enrolling additional providers to allow for 
tracking the impact and intensity of activity of any potential pandemic influenza in 
their state. To enroll additional providers, contact Alicia Postema at 404-639­
3747 or by email at apostema@cdc.gov.
During the past several years, many states have conducted influenza surveillance year round, 
including the summer months. To enhance surveillance nationwide, we strongly encourage all 
states to adopt this practice and continue both laboratory and sentinel provider surveillance 
activities year round, uninterrupted.
Hospital-based specimen collection
States should ask hospitals to perform viral culture on all patients meeting both of 
the following criteria:
1. Patient hospitalized with unexplained pneumonia, acute respiratory
distress syndrome (ARDS), or severe respiratory illness
2. Travel to Asia within 10 days from onset of symptoms
All such patients should be tested for influenza virus infection by viral culture of 
nasopharyngeal and throat swabs. All influenza viruses detected should be typed 
and subtyped, and those not identified as H3, H1, or B should be referred 
immediately to CDC for testing for influenza A(H5N1). Laboratory 
recommendations for handling potential H5N1 samples will follow in the near 
future.
Mortality surveillance
CDC will continue to track mortality through the 122 Cities Mortality Reporting 
System. We will be able to analyze these data on a national and potentially 
regional basis only. This system is based on only a sample of deaths and cannot 
provide state-based estimates of mortality. States anticipating the need to report 
deaths on a state level in the event of a pandemic should begin to explore other 
options for data collection.
Step 2. Activities to be implemented if cases of influenza A(H5N1)illness are 
identified outside Hong Kong or the Chinese mainland OR evidence of 
efficient, sustained, person-to-person transmission is established
Laboratory surveillance
US WHO collaborating laboratories will be requested to report more frequently 
and should anticipate the possible need for daily reporting. Any state laboratories 
wishing to institute electronic reporting through the Public Health Laboratory 
Information System (PHLIS) should contact Lynnette Brammer at 404-639-3747 
or by email at lbrammer@cdc.gov. Instructions for frequent reporting by other 
methods will follow.
Hospital-based surveillance
CDC is exploring options for hospital-based surveillance for influenza-related 
hospital admissions. More information will follow in the near future.
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